Description
Caris Life Sciences is seeking an Account Executive for MI Clarity to drive awareness, adoption, and utilization of an AI-powered prognostic assay designed to assess distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. This role involves partnering with healthcare professionals to educate them on the clinical value of the test, integrating it into clinical workflows, and increasing its appropriate utilization.

